ID

44297

Beskrivning

A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00550173

Länk

https://clinicaltrials.gov/show/NCT00550173

Nyckelord

  1. 2018-07-28 2018-07-28 -
  2. 2021-09-20 2021-09-20 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

20 september 2021

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Non-Small-Cell Lung Cancer NCT00550173

Eligibility Non-Small-Cell Lung Cancer NCT00550173

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with locally advanced or metastatic nonsquamous non-small cell lung cancer
Beskrivning

Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally | Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Datatyp

boolean

Alias
UMLS CUI [1,1]
C4324656
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C1517927
UMLS CUI [2]
C4288755
patients must be non-smokers
Beskrivning

Non-smoker

Datatyp

boolean

Alias
UMLS CUI [1]
C0337672
patients must have at least one measurable lesion
Beskrivning

Measurable lesion Quantity

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
performance status of 0 to 2 on the eastern cooperative oncology group scale
Beskrivning

ECOG performance status

Datatyp

boolean

Alias
UMLS CUI [1]
C1520224
patients must have failed only one prior chemotherapy regimen and must be considered eligible for further chemotherapy following progression of their disease.
Beskrivning

Prior Chemotherapy Quantity failed | Disease Progression | Eligibility Chemotherapy Additional

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0231175
UMLS CUI [2]
C0242656
UMLS CUI [3,1]
C1548635
UMLS CUI [3,2]
C0392920
UMLS CUI [3,3]
C1524062
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who have received treatment within the last 30 days with a drug that has not received regulatory approval for any indication
Beskrivning

Drugs, Non-Prescription

Datatyp

boolean

Alias
UMLS CUI [1]
C0013231
patients who have previously received treatment with drugs against the human epidermal growth factor receptors
Beskrivning

Pharmaceutical Preparations Against Epidermal Growth Factor Receptor

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0521124
UMLS CUI [1,3]
C0034802
patients who have previously received treatment with drugs which have similar targets as pemetrexed
Beskrivning

Pharmaceutical Preparations Pemetrexed Similar

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0210657
UMLS CUI [1,3]
C2348205
patients who have any known significant ophthalmologic abnormalities of the surface of the eye
Beskrivning

Eye Abnormalities Surface

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0015393
UMLS CUI [1,2]
C4321570
patients who have a history of severe hypersensitivity reaction to erlotinib or pemetrexed
Beskrivning

Severe allergy erlotinib | Severe allergy pemetrexed

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2945656
UMLS CUI [1,2]
C1135135
UMLS CUI [2,1]
C2945656
UMLS CUI [2,2]
C0210657

Similar models

Eligibility Non-Small-Cell Lung Cancer NCT00550173

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally | Metastatic Non-Squamous Non-Small Cell Lung Carcinoma
Item
patients with locally advanced or metastatic nonsquamous non-small cell lung cancer
boolean
C4324656 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C4288755 (UMLS CUI [2])
Non-smoker
Item
patients must be non-smokers
boolean
C0337672 (UMLS CUI [1])
Measurable lesion Quantity
Item
patients must have at least one measurable lesion
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
ECOG performance status
Item
performance status of 0 to 2 on the eastern cooperative oncology group scale
boolean
C1520224 (UMLS CUI [1])
Prior Chemotherapy Quantity failed | Disease Progression | Eligibility Chemotherapy Additional
Item
patients must have failed only one prior chemotherapy regimen and must be considered eligible for further chemotherapy following progression of their disease.
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0242656 (UMLS CUI [2])
C1548635 (UMLS CUI [3,1])
C0392920 (UMLS CUI [3,2])
C1524062 (UMLS CUI [3,3])
Item Group
C0680251 (UMLS CUI)
Drugs, Non-Prescription
Item
patients who have received treatment within the last 30 days with a drug that has not received regulatory approval for any indication
boolean
C0013231 (UMLS CUI [1])
Pharmaceutical Preparations Against Epidermal Growth Factor Receptor
Item
patients who have previously received treatment with drugs against the human epidermal growth factor receptors
boolean
C0013227 (UMLS CUI [1,1])
C0521124 (UMLS CUI [1,2])
C0034802 (UMLS CUI [1,3])
Pharmaceutical Preparations Pemetrexed Similar
Item
patients who have previously received treatment with drugs which have similar targets as pemetrexed
boolean
C0013227 (UMLS CUI [1,1])
C0210657 (UMLS CUI [1,2])
C2348205 (UMLS CUI [1,3])
Eye Abnormalities Surface
Item
patients who have any known significant ophthalmologic abnormalities of the surface of the eye
boolean
C0015393 (UMLS CUI [1,1])
C4321570 (UMLS CUI [1,2])
Severe allergy erlotinib | Severe allergy pemetrexed
Item
patients who have a history of severe hypersensitivity reaction to erlotinib or pemetrexed
boolean
C2945656 (UMLS CUI [1,1])
C1135135 (UMLS CUI [1,2])
C2945656 (UMLS CUI [2,1])
C0210657 (UMLS CUI [2,2])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial